Background/objectives <p>This study aimed to develop an interpretable artificial intelligence (AI) screening system that replicates a specialist’s evaluation of fundus photographs. The system analyses three signs: visible retinal nerve fibre layer (RNFL) defects (as observed on fundus photography, not OCT-based measurement), vertical cup-to-disc ratio (VCDR) and rim-to-disc ratio (RDR).</p> Subjects/methods <p>A total of 773 fundus images from the independent test cohort were annotated by three fellowship-trained glaucoma specialists, followed by repeated consensus meetings to improve annotation consistency. Two models were trained on the development cohort: an EfficientNet-B4 classifier for RNFL and a U-Net with an EfficientNet-B4 encoder for optic disc/cup (OD/OC) segmentation. During the testing phase, a referral was triggered whenever a feature was classified as abnormal, with the system explicitly reporting the specific sign that prompted the referral decision.</p> Results <p>Among the 773 expert-annotated cases, 749 were included in the analysis after excluding low-quality or insufficient-information images (AI drop rate: 3.1%). The final independent test cohort comprised 268 referral and 481 non-referral cases, providing a basis for evaluation. The combined model achieved a sensitivity of 0.903 (95% confidence interval [CI], 0.868–0.938), specificity of 0.821 (95% CI, 0.787–0.855) and a positive predictive value (PPV) of 0.738 (95% CI, 0.690–0.785). The system captured complementary aspects of glaucomatous optic neuropathy that are often missed by single-feature approaches.</p> Conclusions <p>Consensus-based annotation, combined with lesion-level modelling, enhances alignment with clinical reasoning. By providing an explicit referral rationale, the system fosters trust in AI-assisted glaucoma screening and facilitates adoption in clinical settings.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Clinically aligned artificial intelligence for glaucoma diagnosis: enhancing retinal nerve fibre layer interpretation from fundus images

  • Shang-Lin Chung,
  • Jehn-Yu Huang,
  • Yi-Ching Shao,
  • Chien-Chia Su,
  • Yun Hsia,
  • Pai-Huei Peng,
  • Pei-Yao Chang,
  • Bo-I Kuo,
  • Chien-Hung Li,
  • Ming-Chi Kuo,
  • Yi-Jin Huang,
  • Wei-Hao Chang,
  • Kai-Cheng Hsu,
  • Chia-En Lien

摘要

Background/objectives

This study aimed to develop an interpretable artificial intelligence (AI) screening system that replicates a specialist’s evaluation of fundus photographs. The system analyses three signs: visible retinal nerve fibre layer (RNFL) defects (as observed on fundus photography, not OCT-based measurement), vertical cup-to-disc ratio (VCDR) and rim-to-disc ratio (RDR).

Subjects/methods

A total of 773 fundus images from the independent test cohort were annotated by three fellowship-trained glaucoma specialists, followed by repeated consensus meetings to improve annotation consistency. Two models were trained on the development cohort: an EfficientNet-B4 classifier for RNFL and a U-Net with an EfficientNet-B4 encoder for optic disc/cup (OD/OC) segmentation. During the testing phase, a referral was triggered whenever a feature was classified as abnormal, with the system explicitly reporting the specific sign that prompted the referral decision.

Results

Among the 773 expert-annotated cases, 749 were included in the analysis after excluding low-quality or insufficient-information images (AI drop rate: 3.1%). The final independent test cohort comprised 268 referral and 481 non-referral cases, providing a basis for evaluation. The combined model achieved a sensitivity of 0.903 (95% confidence interval [CI], 0.868–0.938), specificity of 0.821 (95% CI, 0.787–0.855) and a positive predictive value (PPV) of 0.738 (95% CI, 0.690–0.785). The system captured complementary aspects of glaucomatous optic neuropathy that are often missed by single-feature approaches.

Conclusions

Consensus-based annotation, combined with lesion-level modelling, enhances alignment with clinical reasoning. By providing an explicit referral rationale, the system fosters trust in AI-assisted glaucoma screening and facilitates adoption in clinical settings.